Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera ; volume:30 ; number:1 ; day:26 ; month:4 ; year:2023 ; pages:1-21 ; date:12.2023
Journal of biomedical science ; 30, Heft 1 (26.4.2023), 1-21, 12.2023
- Urheber
-
Tseng, Yu-Ling
Lu, Po-Chao
Lee, Chi-Chang
He, Ruei-Yu
Huang, Yung-An
Tseng, Yin-Chen
Cheng, Ting-Jen Rachel
Huang, Joseph Jen-Tse
Fang, Jim-Min
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12929-023-00921-7
- URN
-
urn:nbn:de:101:1-2023090410230042135798
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tseng, Yu-Ling
- Lu, Po-Chao
- Lee, Chi-Chang
- He, Ruei-Yu
- Huang, Yung-An
- Tseng, Yin-Chen
- Cheng, Ting-Jen Rachel
- Huang, Joseph Jen-Tse
- Fang, Jim-Min
- SpringerLink (Online service)
Ähnliche Objekte (12)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers
Development of the first selective proteolysis targeting chimera for the FK506-binding protein 51
Chimera
Chimera
Restoring functional TDP-43 oligomers in ALS and laminopathic cellular models through baicalein-induced reconfiguration of TDP-43 aggregates
A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51)
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers
Development of the first selective proteolysis targeting chimera for the FK506-binding protein 51
Chimera
Chimera
Restoring functional TDP-43 oligomers in ALS and laminopathic cellular models through baicalein-induced reconfiguration of TDP-43 aggregates
A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51)
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51)
Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors
A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers
Development of the first selective proteolysis targeting chimera for the FK506-binding protein 51
Chimera
Chimera
Restoring functional TDP-43 oligomers in ALS and laminopathic cellular models through baicalein-induced reconfiguration of TDP-43 aggregates
A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells
Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51)
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti‐Proliferative Activity in Lung Cancer Cells